James A Geraghty - Net Worth and Insider Trading
James A Geraghty Net Worth
The estimated net worth of James A Geraghty is at least $2 Million dollars as of 2024-05-13. James A Geraghty is the Director of Juniper Pharmaceuticals Inc and owns about 65,153 shares of Juniper Pharmaceuticals Inc (JNP) stock worth over $749,260. James A Geraghty is the Director of Fulcrum Therapeutics Inc and owns about 90,714 shares of Fulcrum Therapeutics Inc (FULC) stock worth over $677,634. James A Geraghty is also the Director of Voyager Therapeutics Inc and owns about 76,588 shares of Voyager Therapeutics Inc (VYGR) stock worth over $646,403. Besides these, James A Geraghty also holds Aceragen Inc (ACGN) , Pieris Pharmaceuticals Inc (PIRS) . Details can be seen in James A Geraghty's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James A Geraghty has not made any transactions after 2021-06-28 and currently still holds the listed stock(s).
Transaction Summary of James A Geraghty
James A Geraghty Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James A Geraghty owns 6 companies in total, including Aceragen Inc (ACGN) , Pieris Pharmaceuticals Inc (PIRS) , and Orchard Therapeutics PLC (ORTX) among others .
Click here to see the complete history of James A Geraghty’s form 4 insider trades.
Insider Ownership Summary of James A Geraghty
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACGN | Aceragen Inc | 2018-08-07 | director |
| PIRS | Pieris Pharmaceuticals Inc | 2018-05-15 | director |
| ORTX | Orchard Therapeutics PLC | 2020-01-01 | director |
 | | 2021-06-28 | director |
| | 2018-09-10 | director |
| | 2018-08-14 | director |
James A Geraghty Latest Holdings Summary
James A Geraghty currently owns a total of 5 stocks. Among these stocks, James A Geraghty owns 65,153 shares of Juniper Pharmaceuticals Inc (JNP) as of March 17, 2017, with a value of $749,260 and a weighting of 35.66%. James A Geraghty owns 90,714 shares of Fulcrum Therapeutics Inc (FULC) as of June 28, 2021, with a value of $677,634 and a weighting of 32.25%. James A Geraghty also owns 76,588 shares of Voyager Therapeutics Inc (VYGR) as of September 10, 2018, with a value of $646,403 and a weighting of 30.77%. The other 2 stocks Aceragen Inc (ACGN) , Pieris Pharmaceuticals Inc (PIRS) have a combined weighting of 1.32% among all his current holdings.
Latest Holdings of James A Geraghty
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JNP | Juniper Pharmaceuticals Inc | 2017-03-17 | 65,153 | 11.50 | 749,260 |
| FULC | Fulcrum Therapeutics Inc | 2021-06-28 | 90,714 | 7.47 | 677,634 |
| VYGR | Voyager Therapeutics Inc | 2018-09-10 | 76,588 | 8.44 | 646,403 |
| ACGN | Aceragen Inc | 2018-08-07 | 65,433 | 0.38 | 24,865 |
| PIRS | Pieris Pharmaceuticals Inc | 2018-05-15 | 250 | 11.15 | 2,788 |
Holding Weightings of James A Geraghty
James A Geraghty Form 4 Trading Tracker
According to the SEC Form 4 filings, James A Geraghty has made a total of 0 transactions in Juniper Pharmaceuticals Inc (JNP) over the past 5 years. The most-recent trade in Juniper Pharmaceuticals Inc is the acquisition of 2,000 shares on March 17, 2017, which cost James A Geraghty around $9,640.
According to the SEC Form 4 filings, James A Geraghty has made a total of 1 transactions in Fulcrum Therapeutics Inc (FULC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fulcrum Therapeutics Inc is the acquisition of 10,000 shares on June 28, 2021, which cost James A Geraghty around $91,600.
According to the SEC Form 4 filings, James A Geraghty has made a total of 0 transactions in Voyager Therapeutics Inc (VYGR) over the past 5 years. The most-recent trade in Voyager Therapeutics Inc is the acquisition of 3,000 shares on September 10, 2018, which cost James A Geraghty around $58,170.
More details on James A Geraghty's insider transactions can be found in the Insider Trading History of James A Geraghty table.Insider Trading History of James A Geraghty
- 1
James A Geraghty Trading Performance
GuruFocus tracks the stock performance after each of James A Geraghty's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James A Geraghty is 29.21%. GuruFocus also compares James A Geraghty's trading performance to market benchmark return within the same time period. The performance of stocks bought by James A Geraghty within 3 months outperforms 10 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James A Geraghty's insider trading performs compared to the benchmark.
Performance of James A Geraghty
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.24 | | | | | |
| Relative Return to S&P 500(%) | 14.75 | | | | | |
James A Geraghty Ownership Network
James A Geraghty Owned Company Details
What does Aceragen Inc do?
Who are the key executives at Aceragen Inc?
James A Geraghty is the director of Aceragen Inc. Other key executives at Aceragen Inc include director & President & CEO Vincent Milano , director & 10 percent owner Pillar Invest Corp , and 10 percent owner Atul Chopra .
Aceragen Inc (ACGN) Insider Trades Summary
Over the past 18 months, James A Geraghty made no insider transaction in Aceragen Inc (ACGN). Other recent insider transactions involving Aceragen Inc (ACGN) include a net sale of 264,324 shares made by Atul Chopra , a net purchase of 21,147 shares made by Pillar Invest Corp , and a net sale of 3,283 shares made by Vincent Milano .
In summary, during the past 3 months, insiders sold 0 shares of Aceragen Inc (ACGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 273,476 shares of Aceragen Inc (ACGN) were sold and 26,965 shares were bought by its insiders, resulting in a net sale of 246,511 shares.
Aceragen Inc (ACGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aceragen Inc Insider Transactions
James A Geraghty Mailing Address
Above is the net worth, insider trading, and ownership report for James A Geraghty. You might contact James A Geraghty via mailing address: C/o Idera Pharmaceuticals, Inc., 167 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
